Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution

Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation

(2016) Brian C. Shaffer et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies

(2016) Viktoria Varbanova et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients

(2016) A. Curti et al.   CLINICAL CANCER RESEARCH

Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia

(2016) Rizwan Romee et al.   Science Translational Medicine

Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells

(2015) L. Ruggeri et al.   HAEMATOLOGICA

Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions

(2015) Simone Battella et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells

(2015) L. Ruggeri et al.   HAEMATOLOGICA

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein

(2014) V. Bachanova et al.   BLOOD

CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph

(2014) P. Carrega et al.   JOURNAL OF IMMUNOLOGY

Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol

(2013) Ulrike Koehl et al.   Frontiers in Oncology

Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia

(2012) A Pérez-Martínez et al.   BONE MARROW TRANSPLANTATION

Hemolytic anemia due to passenger lymphocyte syndrome in solid malignancy patients treated with allogeneic natural killer cell products

(2012) Robert Skeate et al.   TRANSFUSION

Successful “in-flight” activation of natural killer cells during long-distance shipping

(2012) Scott A. Koepsell et al.   TRANSFUSION

Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions

(2012) Hans Klingemann et al.   TRANSFUSION

Clinical Cancer Therapy by NK Cells via Antibody-Dependent Cell-Mediated Cytotoxicity

(2011) Kory L. Alderson et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor–Negative Natural Killer Cells after NKG2A and LIR-1 Blockade

(2010) Robert Godal et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects

(2010) J. A. Olson et al.   BLOOD

Allogeneic natural killer cells for refractory lymphoma

(2010) Veronika Bachanova et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

(2010) Melissa A. Geller et al.   CYTOTHERAPY

NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia

(2010) Jeffrey E. Rubnitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias

(2009) A. Moretta et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model

(2009) N. T. Joncker et al.   JOURNAL OF IMMUNOLOGY

CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A

(2009) D N Eissens et al.   LEUKEMIA

Transfusion-associated graft-versus-host disease: a perspective from a cell therapy laboratory

(2009)   TRANSFUSION

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

(2008) S. Cooley et al.   BLOOD

Human natural killer cells

(2008) M. A. Caligiuri   BLOOD

Up on the tightrope: natural killer cell activation and inhibition

(2008) Lewis L Lanier   NATURE IMMUNOLOGY